These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944 [TBL] [Abstract][Full Text] [Related]
4. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate]. Grabysa R; Cholewa M Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage. Cuspidi C; Meani S; Fusi V; Valerio C; Sala C; Zanchetti A J Hypertens; 2006 Mar; 24(3):573-80. PubMed ID: 16467661 [TBL] [Abstract][Full Text] [Related]
6. The assessment of total cardiovascular risk in hypertensive subjects in primary care. Korhonen PE; Vesalainen RK; Aarnio PT; Saaresranta T; Kautiainen H; Järvenpää S; Kantola IM Ann Med; 2010 Apr; 42(3):187-95. PubMed ID: 20350256 [TBL] [Abstract][Full Text] [Related]
7. Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility. Ayodele OE; Alebiosu CO; Akinwusi PO; Akinsola A; Mejiuni A Niger J Clin Pract; 2007 Dec; 10(4):319-25. PubMed ID: 18293643 [TBL] [Abstract][Full Text] [Related]
8. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765 [TBL] [Abstract][Full Text] [Related]
9. Global risk stratification in primary hypertension: the role of the kidney. Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851 [TBL] [Abstract][Full Text] [Related]
10. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928 [TBL] [Abstract][Full Text] [Related]
11. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917 [TBL] [Abstract][Full Text] [Related]
12. Kidney function and clinical correlates in newly diagnosed hypertensives attending a university teaching hospital in southwest Nigeria. Ayodele OE; Egbewale BE; Alebiosu CO Afr J Med Med Sci; 2007 Jun; 36(2):95-101. PubMed ID: 19205569 [TBL] [Abstract][Full Text] [Related]
13. Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension. Boreu QF; de Tuero GC; Rodríguez-Poncelas A; Albertos MS; Zafra MS; Radó MA; Blood Press; 2007; 16(6):354-61. PubMed ID: 17852096 [TBL] [Abstract][Full Text] [Related]
14. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension. Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience. Hitha B; Pappachan JM; Pillai HB; Sujathan P; Ramakrishna CD; Jayaprakash K; Raihanathul Misiriya KJ Saudi J Kidney Dis Transpl; 2008 May; 19(3):411-9. PubMed ID: 18445902 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive approach to target organ damage in hypertensive women. Modena MG; Rossi R J Hypertens Suppl; 2002 May; 20(2):S66-9. PubMed ID: 12183857 [TBL] [Abstract][Full Text] [Related]
18. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. Henskens LH; van Oostenbrugge RJ; Kroon AA; Hofman PA; Lodder J; de Leeuw PW J Hypertens; 2009 Apr; 27(4):846-53. PubMed ID: 19300113 [TBL] [Abstract][Full Text] [Related]
19. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion. Stenehjem AE; Bjørnerheim R; Os I Blood Press; 2007; 16(2):87-94. PubMed ID: 17612906 [TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]